Parkinson's Flashcards

1
Q

Three classifications of parkinson’s disease?

A

1) idiopathic
2) iatrogenic
3) post-traumatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In PD, dopamine neurons die off, causing less dopamine release in the ___

A

striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In the striatum, there’s an association between ___ and ___-producing neurons

A

dopamine, ach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When dopaine > Ach what occurs?

A

Parkinsonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When Ach>dopamine what occurs?

A

Choreiform movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Presently available drugs are thought to alleviate symptoms by restoring the functional balance between ___ and ___ systems in the striatum

A

dopaminergic and cholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What three drugs enhance dopaminergic activity?

A

1) L-Dopa
2) Selegiline
3) Entacapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

_____ inhibits the metabolism of dopamine by MAO-B

A

Selegiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

____ inhibits COMT and slows the metabolism of dopamine near the synaptic cleft

A

Entacapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

____ is a dopamine pre-cursor that is converted to dopamine

A

L-Dopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What three drugs are dopamine agonists and stimulate post-synaptic dopamine receptors?

A

1) Bromocryptine
2) Pergolide
3) Pramipexole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What three drugs reduce cholinergic activity and are centrally acting muscarinic antagonists?

A

1) Benztropine
2) Trihexiphenidyl
3) Diphenhydramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is L-dopa typically not used to treat symptoms alone?

A

L-dopa converts to dopamine in periphery, which can cause cardiovascular effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is L-dopa commonly used with?

A

Carbidopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carbiodopa acts in the peripheral to inhibit L-dopa from becoming ___

A

dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How long does it take to see therapeutic effects of L-dopa?

A

3-4 weeks

17
Q

True or False:
L-Dopa becomes more effective as Parkinson’s Disease Progressive

A

False
L-Dopa becomes LESS effective as disease progresses

18
Q

Why is nausea and vomiting a common side effect of L-Dopa?

A

Stimulates chemoreceptor trigger zone (CRTZ)

19
Q

What are three ways that L-Dopa can affect the heart?

A

-Postural hypotension
-Arrhythmias
-Tachy

20
Q

What is the most effective drug for managing the psychiatric side effects of L-Dopa?

A

Clozapine

21
Q

Why are there psychiatric side effects with use of L-Dopa?

A

Acts on mesolimbic and mesocortical pathways

22
Q

True or False:
L-Dopa can cause extrapyramidal motor symptoms/choreiform movements

A

True

23
Q

True or False:
L-dopa can increase prolactin levels

A

False
L-Dopa can decrease prolactin levels

24
Q

The ___ ___ ____ phenomenon appears to be related to decline in blood levels of L-Dopa near the end of the dosage interval

A

End of Dose phenomenon

25
Q

The ____ phenomenon can occur at any time in the dosage interval and appears to be related to disease progression

A

on-off phenomenon

26
Q

How can you minimize the end of dose phenomenon?

A

1) Use SR
2) Add dopaminergic agonist/COMT inhibitor to cocktail

27
Q

Contra-indications for L-dopa?

A

Glaucoma
Active peptic ulcer disease
Melanoma
Psychosis
Cardiac stuff

28
Q

____ inhibits DOPA decarboxylase in the periphery but does not enter the brain

A

Carbidopa

29
Q

____ is a non-specific dopamine receptor agonist that can decrease severity of on off phenomenon

A

bromocryptine

30
Q

What two drugs are newer dopaminergic agonists that may preferentially target D2/D3 receptors?

A

1) Ropinirole
2) Pramipexole

31
Q

____stimulates release of dopamine from nerve ends, but may also inhibit reuptake

A

Amantadine

32
Q

Selegiline selectively inhibits ___ and prevents breakdown of dopamine in CNS

A

MAO-B

33
Q

_____inhibits metabolism of dopamine and L-Dopa by COMT

A

Entacapone